John Paulson's fund is clearly not happy about Abbvie's decision to examine backing out of the Shire deal. Here is what Paulson, who is a big shareholder in both Abbvie and Shire, has just told Bloomberg:
"We believe this transaction creates enormous value for Abbvie shareholders. The combination is both strategic and accretive regardless of the tax considerations. As a large Abbvie shareholder we hope the Abbvie Board reaffirms its commitment to the transaction after its review’’:
No comments:
Post a Comment